Veritas Genetics Stock

Genetic testing platform

Sign up today and learn more about Veritas Genetics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Philab Holdings Corp


Danvers MA, US

Total Funding


About Veritas Genetics Stock

Veritas Genetics is a provider of a genetic testing platform intended to empower people to live healthier and longer. The company's genetic technology can detect a wider range of variations in a gene than are typically found in next-generation sequencing and offers a screening test for hereditary breast and ovarian cancer risk, enabling clinical researchers and physicians in order to make informed decisions.


Lilly Asia Ventures

Veritas Genetics

Philab Holdings Corp

Veritas Genetics

Simcere Pharma

Veritas Genetics

Funding History

June 2015$12.0M
October 2016$30.0M
January 2018$4.6M
February 2018$500M


Co-Founder & Chief Executive Officer

Mirza Cifric

Co-Founder & Managing Director, Asia

Jonathan Zhao

Chief Commercial Officer & General Counsel

Douglas Flood


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: